The COVID-19 pandemic is by no means over. A report published by CIFS, one of our research partnerships, explains that we should recognise the urgent need to manage the ravages of the pandemic while taking the decisions to minimise the effects of a second or third wave. Furthermore, we need to prepare for the risk of a currently unknown disease again reaching a pandemic scale.
It is irrefutable that we had the technology, experience, and knowledge needed to respond to the COVID-19 pandemic in a coordinated, timely, and controlled way. It is also undeniable that in most countries, this did not happen to the extent necessary. Rather, the objective must be to look forward to the other side of this pandemic and take full advantage of the evolution of medicine, technology, Big Data, genomics, IoT, AI.
The risk landscape around future disease outbreaks and pandemics, natural or engineered, demands new regulation and interdisciplinary engagement within the global scientific community. Additionally, as these risks are constantly evolving, our understanding of how to co-evolve with them requires exploration of extreme scenarios and sustained global institutional collaboration.
One of the most recent developments (as of late May 2020), is that the antiviral medication Remdesivir has been shown to significantly lower mortality of COVID-19 if provided at an early enough time. While this is no cure, it may turn out to be a contributor to lessoning the threat of the disease.
Meanwhile, research into an actual vaccine is ongoing, and much depends on whether or not we manage to find one - and if we do, how fast we are able to produce and distribute it on a global scale.
While it is too early to tell how these and other ongoing developments will play out, and what their impacts will be, it has become clear that the eradication of the disease will not bring us back to the world as it was before. Now is the time to look ahead to try and reimagine our systems and structures and use this catastrophe as a chance to reassess the status quo.
Just like a tsunami warning system, there are already early warning systems for epidemics and pandemics. For many countries and regions, the reason why these systems were not used to their full potential was not a matter of not having the right technology available, but mainly due to political barriers, wilful negligence, or poor implementation.
Pandemic preparedness is like health insurance: you hope to never collect on it, and it is easy to lose sight of the danger. Overcoming transnational and intergenerational risks will require creative solutions and shared political will. Our current pandemic has made clear that our existing response frameworks focus primarily on combatting outbreaks on the national level, and the international patchwork of responses we have seen will not suffice when the next pandemic, potentially with higher contagiousness and/or higher mortality, comes around.
The COVID-19 pandemic has laid bare the vulnerabilities and shortcomings in global health by pushing the limits of healthcare systems. However, healthcare professionals are now seeing how health-related data can make the crucial difference between life and death, and digital health technologies are being rapidly implemented into existing health systems to curb the virus, with telemedicine finally maturing and becoming a lifesaving tool. It is time to collaborate across jurisdictions with new forms of data and an even more widespread use of digital health technologies, enabling remote care and predictive public healthcare, as well as more preventive care.
What our governments must now do is find a way to implement it without letting Big Tech companies dictate the terms or scare us away from the benefits by engaging in a controlled partnership with them. This also goes for behavioural data and contact tracing technology such as the announced co-operation between Apple and Google.
We require transparency, traceability, and accountability for our data, ensuring that standards are kept, and that health data does not become a tool in the hands of the few.
While there is an ongoing and valid debate about where we draw the line between individual privacy and health data monitoring, the technology and visions are there.
Now, we need safe ways to implement them.
The pandemic has provoked an unprecedented level of response from policymakers around the globe. In the first quarter of 2020, more than 1.700 economic policy announcements on COVID-19 have been made by governments and institutions worldwide. Although most of the political devotion in this phase of forced experimentation is attentive to the immediate crisis response, some nations are seizing this momentum to fast track policies that represent more substantial, long-term shifts towards new paradigms.
Beyond economic stimulus and relief packages, the need for more decentralised approaches to urban planning made clear by the pandemic may have been the much-needed push towards the next generation of smart cities. In other countries and cities, initiatives that have long lain dormant on the theoretical drawing board have been quickly implanted.
Spain has, as the first country in Europe, introduced universal basic income. In Amsterdam, the city government has adopted the so-called ‘doughnut model’ for sustainable growth, which incorporates 12 metrics for social wellbeing as well as 9 ecological ceilings metrics. Initiatives such as these point towards a widespread need to prevent a reversion to old ways of thinking and acting after the crisis.
No country can deal with pandemics on its own. Not only are national healthcare resources impacted differently across the globe, but the knowledge of how to deal with the aftermath of the COVID-19 pandemic will also be scattered – maybe even in such a way that one country has more in common with a country in another region than its immediate neighbours. To meet the future as a more prepared global society, we need both the creation of public private partnerships with long-term goals, as well as the inclusion of civil society organisations in activities that aim to improve our preparedness locally, nationally, regionally, and globally.
Important legal information
This marketing material is issued by Pictet Asset Management (Europe) S.A.. It is neither directed to, nor intended for distribution or use by, any person or entity who is a citizen or resident of, or domiciled or located in, any locality, state, country or jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation. The latest version of the fund‘s prospectus, Pre-Contractual Template (PCT) when applicable, Key Information Document (KID), annual and semi-annual reports must be read before investing. They are available free of charge in English on www.assetmanagement.pictet or in paper copy at Pictet Asset Management (Europe) S.A., 6B, rue du Fort Niedergruenewald, L-2226 Luxembourg, or at the office of the fund local agent, distributor or centralizing agent if any.
The KID is also available in the local language of each country where the compartment is registered. The prospectus, the PCT when applicable, and the annual and semi-annual reports may also be available in other languages, please refer to the website for other available languages. Only the latest version of these documents may be relied upon as the basis for investment decisions.
The summary of investor rights (in English and in the different languages of our website) is available here and at www.assetmanagement.pictet under the heading "Resources", at the bottom of the page.
The list of countries where the fund is registered can be obtained at all times from Pictet Asset Management (Europe) S.A., which may decide to terminate the arrangements made for the marketing of the fund or compartments of the fund in any given country.
The information and data presented in this document are not to be considered as an offer or solicitation to buy, sell or subscribe to any securities or financial instruments or services.
Information, opinions and estimates contained in this document reflect a judgment at the original date of publication and are subject to change without notice. The management company has not taken any steps to ensure that the securities referred to in this document are suitable for any particular investor and this document is not to be relied upon in substitution for the exercise of independent judgment. Tax treatment depends on the individual circumstances of each investor and may be subject to change in the future. Before making any investment decision, investors are recommended to ascertain if this investment is suitable for them in light of their financial knowledge and experience, investment goals and financial situation, or to obtain specific advice from an industry professional.
The value and income of any of the securities or financial instruments mentioned in this document may fall as well as rise and, as a consequence, investors may receive back less than originally invested.
The investment guidelines are internal guidelines which are subject to change at any time and without any notice within the limits of the fund's prospectus. The mentioned financial instruments are provided for illustrative purposes only and shall not be considered as a direct offering, investment recommendation or investment advice. Reference to a specific security is not a recommendation to buy or sell that security. Effective allocations are subject to change and may have changed since the date of the marketing material.
Past performance is not a guarantee or a reliable indicator of future performance. Performance data does not include the commissions and fees charged at the time of subscribing for or redeeming shares.
Any index data referenced herein remains the property of the Data Vendor. Data Vendor Disclaimers are available on assetmanagement.pictet in the “Resources” section of the footer. This document is a marketing communication issued by Pictet Asset Management and is not in scope for any MiFID II/MiFIR requirements specifically related to investment research. This material does not contain sufficient information to support an investment decision and it should not be relied upon by you in evaluating the merits of investing in any products or services offered or distributed by Pictet Asset Management.
Pictet AM has not acquired any rights or license to reproduce the trademarks, logos or images set out in this document except that it holds the rights to use any entity of the Pictet group trademarks. For illustrative purposes only.